Frontiers in Public Health (Dec 2023)

Trends in outpatient and inpatient visits for separate ambulatory-care-sensitive conditions during the first year of the COVID-19 pandemic: a province-based study

  • Tetyana Kendzerska,
  • Tetyana Kendzerska,
  • Tetyana Kendzerska,
  • David T. Zhu,
  • David T. Zhu,
  • Michael Pugliese,
  • Michael Pugliese,
  • Douglas Manuel,
  • Douglas Manuel,
  • Mohsen Sadatsafavi,
  • Marcus Povitz,
  • Therese A. Stukel,
  • Therese A. Stukel,
  • Therese A. Stukel,
  • Teresa To,
  • Teresa To,
  • Teresa To,
  • Teresa To,
  • Shawn D. Aaron,
  • Shawn D. Aaron,
  • Sunita Mulpuru,
  • Sunita Mulpuru,
  • Melanie Chin,
  • Melanie Chin,
  • Claire E. Kendall,
  • Claire E. Kendall,
  • Claire E. Kendall,
  • Kednapa Thavorn,
  • Kednapa Thavorn,
  • Kednapa Thavorn,
  • Rebecca Robillard,
  • Andrea S. Gershon,
  • Andrea S. Gershon,
  • Andrea S. Gershon,
  • Andrea S. Gershon,
  • Andrea S. Gershon,
  • Andrea S. Gershon

DOI
https://doi.org/10.3389/fpubh.2023.1251020
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundThe COVID-19 pandemic led to global disruptions in non-urgent health services, affecting health outcomes of individuals with ambulatory-care-sensitive conditions (ACSCs).MethodsWe conducted a province-based study using Ontario health administrative data (Canada) to determine trends in outpatient visits and hospitalization rates (per 100,000 people) in the general adult population for seven ACSCs during the first pandemic year (March 2020–March 2021) compared to previous years (2016–2019), and how disruption in outpatient visits related to acute care use. ACSCs considered were chronic obstructive pulmonary disease (COPD), asthma, angina, congestive heart failure (CHF), hypertension, diabetes, and epilepsy. We used time series auto-regressive integrated moving-average models to compare observed versus projected rates.ResultsFollowing an initial reduction (March–May 2020) in all types of visits, primary care outpatient visits (combined in-person and virtual) returned to pre-pandemic levels for asthma, angina, hypertension, and diabetes, remained below pre-pandemic levels for COPD, and rose above pre-pandemic levels for CHF (104.8 vs. 96.4, 95% CI: 89.4–104.0) and epilepsy (29.6 vs. 24.7, 95% CI: 22.1–27.5) by the end of the first pandemic year. Specialty visits returned to pre-pandemic levels for COPD, angina, CHF, hypertension, and diabetes, but remained above pre-pandemic levels for asthma (95.4 vs. 79.5, 95% CI: 70.7–89.5) and epilepsy (53.3 vs. 45.6, 95% CI: 41.2–50.5), by the end of the year. Virtual visit rates increased for all ACSCs. Among ACSCs, reductions in hospitalizations were most pronounced for COPD and asthma. CHF-related hospitalizations also decreased, albeit to a lesser extent. For angina, hypertension, diabetes, and epilepsy, hospitalization rates reduced initially, but returned to pre-pandemic levels by the end of the year.ConclusionThis study demonstrated variation in outpatient visit trends for different ACSCs in the first pandemic year. No outpatient visit trends resulted in increased hospitalizations for any ACSC; however, reductions in rates of asthma, COPD, and CHF hospitalizations persisted.

Keywords